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RESEARCH ARTICLE Open Access
Current phototherapy practice on Java,
Indonesia
Mahendra T. A. Sampurna1* , Kinanti A. Ratnasari1, Darto Saharso1, Arend F. Bos2, Pieter J. J. Sauer2,
Peter H. Dijk2 and Christian V. Hulzebos2
Abstract
Background: In Indonesia, the burden of severe hyperbilirubinemia is higher compared to other countries. Whether
this is related to ineffective phototherapy (PT) is unknown. The aim of this study is to investigate the performance of
phototherapy devices in hospitals on Java, Indonesia.
Methods: In 17 hospitals we measured 77 combinations of 20 different phototherapy devices, with and without curtains
drawn around the incubator/crib. With a model to mimic the silhouette of an infant, we measured the irradiance levels
with an Ohmeda BiliBlanket Meter II, recorded the distance between device and model, and compared these to
manufacturers’ specifications.
Results: In nine hospitals the irradiance levels were less than required for standard PT: < 10 μW/cm2/nm and in
eight hospitals irradiance failed to reach the levels for intensive phototherapy: 30 μW/cm2/nm. Three hospitals
provided very high irradiance levels: > 50 μW/cm2/nm. Half of the distances between device and model were
greater than recommended. Distance was inversely correlated with irradiance levels (R2 = 0.1838; P < 0.05). The
effect of curtains on irradiance levels was highly variable, ranging from − 6.15 to + 15.4 μW/cm2/nm, with a mean
difference (SD) of 1.82 (3.81) μW/cm2/nm (P = 0.486).
Conclusions: In half of the hospitals that we studied on Java the levels of irradiance are too low and, in some cases,
too high. Given the risks of insufficient phototherapy or adverse effects, we recommend that manufacturers provide
radiometers so hospitals can optimize the performance of their phototherapy devices.
Keywords: Curtain, Distance, Hyperbilirubinemia, Irradiance, Phototherapy
Key notes
 Inappropriate phototherapy may contribute to
the high burden of severe hyperbilirubinemia in
Indonesia: increase the risk of bilirubin
encephalopathy as well as the number of
exchange transfusions.
 In half of the hospitals that we studied irradiance
levels were too low, while in some the levels were
very high.
 Half the distances between device and model were
greater than recommended.
Background
Worldwide, hyperbilirubinemia contributes 40 to 60% of
neonatal hospital admissions [1]. Untreated hyperbiliru-
binemia may cause neurotoxicity that ultimately results in
one of the kernicterus spectrum disorders [2]. A recent
survey in Indonesia indicated a 7% incidence of
hyperbilirubinemia, defined as a serum bilirubin level
of > 340 μmol/L (20 mg/dL), in all newborn infants
[3]. Acute bilirubin toxicity was found in 2% of newborn
infants admitted [3]. Why the incidence and burden of
hyperbilirubinemia is much higher in Indonesia compared
to other countries is unknown.
Phototherapy (PT) has proven to be effective in redu-
cing levels of unconjugated bilirubin. Worldwide there are
many different guidelines indicating when to start and
when to stop administering PT [4–6]. Studies have shown
that PT can reduce total serum bilirubin (TSB) levels and
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thus prevent neurotoxicity and kernicterus spectrum dis-
orders [7, 8]. For it to be effective, however, PT requires a
specific level of irradiance. Studies carried out in both
high-income and low-and-middle-income countries re-
ported considerable variance in the irradiance levels of the
PT devices used [9–11]. In a number of devices irradiance
levels were suboptimal or insufficient, possibly causing
ineffective treatment, while aggressive PT and too high
levels of irradiance may be dangerous and associated with
adverse effects [12, 13].
The irradiance levels of PT also depend on the distance
between the PT device and the infant. All guidelines and
manufacturers’ information provide recommendations
concerning optimal and safe distances, but it is not clear
how critical the effect of the actual distance is on irra-
diance levels. General practice in Indonesia is to cover the
incubators or cribs with curtains when PT is administered.
This is done to protect other infants in the room against
the light and to increase the irradiance of the PT by
reflection. Using reflective curtains may reduce TSB
levels more rapidly than not using reflective curtains
[5]. It is unknown, however, whether non-reflective
curtains will also increase the effectiveness of PT. The
aim of this study was to investigate the irradiance levels of
PT in clinical practice in Indonesia. In addition, we
analyzed the effect of distance between the PT device and
the infant, and the effect of curtains on irradiance levels.
Methods
Between December 2016 and August 2017 we visited 17
hospitals with Level II and Level III neonatal intensive
care units (NICUs) on Java, Indonesia to measure the
irradiance levels of PT devices. We had intended to
study overhead as well as underneath PT devices in a
clinical setting, but because we found only one under-
neath PT device, which was no longer in use anyway, we
excluded underneath PT devices. Local NICU nurses
placed a model of the silhouette of a preterm infant once
in the incubator or crib and installed the overhead PT
device as they would in daily practice. We had marked
the model with five measurement points at 3, 12, 18, 23,
and 33 cm apart, to represent an infant’s head, trunk, ab-
domen, knees, and feet [9]. If a device had more than one
irradiation mode we measured the highest irradiance level
of that PT device. The second series of irradiance measure-
ments were done once using curtains if this was routine
practice in that specific hospital. The nurses drew the
curtain around the incubator or crib as they would do in
everyday practice. Irradiance levels were measured in
exactly the same way as without the curtains.
We measured irradiance using a new Ohmeda Bili-
Blanket Meter II (Konica Minolta Inc., Tokyo, Japan)
that had been calibrated before use by the manufacturer.
According to the specifications of the manufacturer, only
one calibration per year is needed. All our measurements
were done within the year of the calibration. This radiom-
eter is designed to measure light radiation with a band-
width range of 400 to 520 nm and peak sensitivity at 450
nm. The measuring range of the spectral irradiance is from
0.1 to 299.9 μw/cm2/nm. Standard PT was defined as PT
with irradiance levels between 10 and 30 μw/cm2/nm. If
irradiance levels were above 30 μw/cm2/nm, PT was
defined as intensive PT [4].
For each PT device we used the mean values of the
five replications for further calculations. Per device the
means of all measurement points were averaged to one
mean intensity level, in agreement with the definition of
the effective surface area by the International Electro-
technical Commission and in agreement with the AAP
recommendations [4].
To evaluate the effect of distance on irradiance level, we
measured the distance in cm between the PT device and
silhouette model at the measurement point closest to the
PT device. One silhouette was used for all measurements.
It is a two dimensional model with a brown color. We
searched for specifications of the phototherapy devices
and recommendations of the manufacturers by searching
the internet using the names of the devices and the official
websites of the manufacturers.
The study was approved by the Ethical Committee in
Health Research of the Dr. Soetomo General Hospital
Surabaya (number 390/Panke.KKE/V/2017). The need to
ask Ethical approval and the need to ask consent from
parents was waived by our Ethical Committee because
no human subjects were involved in this study.
Data and statistical analysis
We used SPSS for Windows, Version 21 (IBM., Corp,.
Armonk, N.Y., USA) for data analysis. First, we calcu-
lated the medians and ranges of the irradiance levels for
each device. Five measurements were done for each
point of the silhouette. The mean of the five measure-
ments was calculated. Next, the mean and range of the
five means was used for the analysis of the total irra-
diance. Second, we plotted the mean irradiance levels of
the PT devices of each hospital in a graph. Third, we
analysed the relationship of the irradiance levels with the
distance between the PT device and the model using
linear regression analysis. We compared the measured
irradiance levels and the distances with those stated in the
manufacturers’ specifications by using independent sample
T tests, and we constructed Bland-Altman graphs to ana-
lyse the differences between irradiance levels per device,
with and without curtains, one for irradiance levels below
30 μw/cm2/nm and one for above 30 μw/cm2/nm. We
arbitrarily chose this irradiance level to analyse whether
the effect of curtains on irradiance levels depended on
standard and intensive PT. We used the Mann-Whitney
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test to analyse the differences between irradiance levels
measured with and without curtains. A P value below 0.05
was considered statistically significant.
Results
We measured 77 PT devices of 20 different types in the
17 hospitals we visited. The irradiance levels of all types
of devices included in this study are given in Table 1.
Most types of devices used fluorescent light sources, six
used light-emitting diodes (LEDs), and one used halo-
gen. The irradiance levels of the PT devices varied
widely. In three PT devices all the irradiance levels were
below 10 μW/cm2/nm and in six devices the median
levels were below 10 μW/cm2/nm. Eleven out of 20 PT
devices had a manufacturer’s manual that contained
detailed information on how to use the device and what
irradiance levels the device should produce [14–24]. For
the other nine devices we could not find detailed manu-
facturers’ specifications. Two out of 11 PT devices pro-
vided irradiance levels well below (12% or less) the given
manufacturers’ specification. Six of the nine other devices
with manufacturers’ specifications produced irradiance
levels below the lower range of intensity recommended in
the manufacturers’ specifications.
Regarding the hospitals, we found a wide variation in
the irradiance levels, both between and within hospitals.
Figure 1 shows the mean irradiance levels of all PT
devices in all hospitals. The irradiance levels ranged from
0.68 to 127 μW/cm2/nm. Nine (53%) of the hospitals used
PT devices with an intensity below the standard PT
of 10 μ W/cm2/nm. Eight (47%) of the hospitals did
not have PT devices that produced an intensity of at
least 30 μ W/cm2/nm, the level required for intensive PT.
Three hospitals used PT devices with irradiance levels
above 50 μ W/cm2/nm. These were mostly LED-based
PT devices. The irradiance level of one LED device was
too low.
The distance between the model and PT devices ranged
from 17 to 59 cm (mean ± SD: 37.8 ± 8.3 cm), while the
manufacturers recommended distances ranging from 20
to 40 cm (mean ± SD: 31.9 ± 6.3 cm) that, with a difference
of 5.9 cm, is significantly closer (P < 0.026). Table 1 also
provides the distance between the PT devices and the
infant as recommended by the manufacturers and the
Table 1 Phototherapy devices per hospital, range of irradiance levels, and distances measured and recommended by the
manufacturers














Airshield Foto Tx Systemb 1/1 0.7 (0.5–0.9) – 40 –
Fanem Bilitron 3006c [14] 1/1 2.6 (0.7–3.6) 35–40 40 30
Tesenab [15] 1/1 7.3 (5.4–7.7) 62 24 30
Choongwae PTb 1/ 2 7.9 (5.5–10.3) – 41 (37–45) –
Gammatech PT BGMb 1/ 4 8.3 (7–10.1) – 50 –
My Life MP-71b 4/5 8.6 (6–15.5) – 40 (40–45) 30
GEA XHZ 90b [16] 7/18 11.3 (6.6–39.4) 9–27 40 (25–59) –
Nidea PT 2000–1600b 1/ 2 11.7 (7.1–16.1) – 30 –
Medelab [17] 4/12 13.3 (3.5–38.5) 14–31 30 (28–40) 25–40
YON DON PTb 1/ 2 13.7 (9.1–19.7) – 40 –
Onemed GLQ 2b 1/1 14.7 (13–15.7) – 40 –
Ohmeda 2 pcs PT Light II
Halogen + Philips Blued [18]
1/1 15.9 (8.4–27.8) 3–76 (15–35) 40
Draeger PT 4000b [19] 2/3 19.1 (9.7–35) 14–27 32.5 (30–35) 30–40
GE Lullaby Fluoresensb [20] 1/ 2 23.3 (13.1–25) 20–30 35 30
Philips TL 20W/52 SLV/25b 3/5 30.9 (9.1–36.8) – 35 (29–37) –
Bistos BT 400c [21] 2/3 32.7 (11.9–79.3) > 30 42 (34–50) 30
GE Lullaby LEDc [22] 4/9 39.9 (12.5–57.9) 22–45 40 (32–45) 30
Tende LEDc [23] 2/ 2 46 (36.5–127) 33–120 32.5 (30–35) 40
Seefar 4000 Spotc 1/ 2 65.2 (44.4–80.6) – 25 –
Novos Bilisphere LEDc [24] 1/1 91.4 (65.3–95.7) > 60 17 20
aData provided by the Medical Device Agency (MDA) or Manufacturers in μ W/cm2/nm, the lowest and highest value are presented [14–24]
Type of PT device: bFluorescent, cLED, dHalogen
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distance used in daily practice. We found one half (20 out
of 40) of the distances between device and model to be
greater than the distance recommended by the manufac-
turers. As we show in Fig. 2, there was a significant inverse
relationship between the distance of the PT device to the
model and the irradiance levels, (R2 = 0.1838; P < 0.05).
With every 1 cm increase in distance, intensity decreased
by approximately 1.1 μW/cm2/nm. Thus, the mean differ-
ence between the measured and recommended distance
of 5.9 cm accounts for a mean reduction in intensity of 5.9
times 1.0777 equals 6.4 μW/cm2/nm.
One hospital did not use curtains, eight hospitals used
white curtains, and one hospital used black curtains, the
remaining seven hospitals used a variety of mostly light-
coloured curtains. The difference in irradiance levels, with
and without curtains, was highly variable and ranged from
− 6.15 and + 15.4 μW/cm2/nm per measurement point,
with a mean difference (SD) of 1.82 (3.81) μW/cm2/nm,
and the overall effect was not significant (P = 0.486). In
Fig. 3 we present the difference in irradiation levels per
device, with and without curtains, for standard PT with
irradiance levels below 30 μ W/cm2/nm, and in Fig. 4 for
intensive PT with irradiance levels above 30 μ W/cm2/nm.
For irradiance levels below 30 μ W/cm2/nm, the mean
(SD) difference was 1.05 (2.08) μ W/cm2/nm higher
with curtains (P = 0.370). Above 30 μ W/cm2/nm, the
mean (SD) difference for irradiation levels was 2.58
(4.37) μ W/cm2/nm higher with curtains, but it also
failed to reach statistical significance (P = 0.572). The
raw data of PT irradiance from all hospital is pro-
vided in Additional file 1.
Discussion
In this observational study we found that the intensity of
phototherapy varied considerably both within and between
hospitals on Java, in Indonesia. Devices with irradiance
levels below which PT is recommended were in use in
more than half of the hospitals. Moreover, nearly half of
the hospitals did not have devices that provided sufficient
irradiance for intensive PT. By contrast, some hospitals
had PT devices that produced very high irradiance levels
that perhaps enhanced the efficacy of PT [25, 26], but were
perhaps not always safe [12, 13]. Altogether, the effect of
PT on hyperbilirubinemia may be highly unpredictable.
The irradiance levels of the PT devices varied consid-
erably, with a high percentage of ineffective standard
and intensive PT. This finding was in line with other
studies performed in either developed or developing
countries [9–11]. According to Bhutani and colleagues,
there are four different explanations for low irradiance
levels of PT in developing countries [27]. First, the
sources of light may be inferior. Second, maintenance
Fig. 1 Mean irradiance levels of all phototherapy devices for each of the 17 hospitals on Java, Indonesia. The unbroken line in the graph indicates
the level above which standard phototherapy is effective (10 μW/cm2/nm) and the broken line indicates the level above which phototherapy is
considered intensive PT (30 μW/cm2/nm)
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constraints may play a role. Third, countries may lack a
steady supply of electrical power. Lastly, awareness of
the requirements for effective phototherapy may be
lacking, such as the importance of the distance between
the infant and the PT device.
The most likely explanations for the low levels of
irradiance found on Java are inferior PT devices, lack of
awareness of the requirements for effective PT, insuffi-
cient maintenance, and too great a distance between the
infant and the PT device. Increasing awareness of the
Fig. 3 Bland-Altman plot showing the difference of irradiance levels of each phototherapy device, with curtains compared to without curtains,
for those phototherapy devices that had irradiance levels below 30 μw/cm2/nm. Each phototherapy device presents one dot, the mean (SD)
difference was 1.05 (2.08) μW/cm2/nm higher when using curtains (P = 0.370)
Fig. 2 The relationship between the distance of the phototherapy device and the model and the mean irradiance levels of each device,
measured without curtains. For the irradiance levels we calculated the mean of the measurements of the five points marked on the
model (see Methods). The line in the graph represents the regression line, the concomitant formula is presented in the upper right-hand
corner of the graph
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factors that affect PT efficacy will undoubtedly result in
better performance of the devices and smaller distances
[28]. The AAP recommends measuring the intensity of
PT devices regularly [4]. On Java, however, none of the
hospitals we visited had a radiometer to measure irra-
diance. Neither did any of the companies that supplied
the PT devices to the hospitals also provide radiometers.
We do not know whether this is due to a lack of aware-
ness on the part of the suppliers of PT devices or on the
part of those who purchase PT devices, or whether other
constraints play a role. Furthermore, it is common
knowledge that irradiance levels of conventional lamps
and tubes decrease with use. These lamps and tubes
should therefore be checked periodically and replaced if
necessary. In most hospitals on Java, however, it is not
customary to replace PT lamps that still seem to be
working properly. On the other hand, it is not possible
to check whether a PT device is functioning properly
without a radiometer. Our results are in line with data
from Nigeria, where routine irradiance monitoring is
also uncommon, whereas periodically monitoring of
irradiance is recommended [29, 30].
The majority of PT devices with low irradiance were
fluorescent tube-based devices, but there was one LED-
based PT device that had low irradiance. Olusanya and
colleagues found that irradiance decay was higher and
occurred faster in fluorescent tube-based PT devices
compared to LED-based PT devices [29]. LED-based PT
devices also show irradiance decay, but after a much
longer period of use. LED-based PT devices may last
up to 20,000 h while fluorescent tube-based PT devices
may require lamp replacement every 3000 h [27]. There-
fore, LED-based PT should be preferred in resource-
constrained settings. Nevertheless, regular irradiance
monitoring is always essential, also in resource-constrained
settings [4, 30].
Only for 11 of the 20 devices used, did we find the
manufacturers’ specifications. This is odd, because with-
out these specifications healthcare workers cannot be
expected to know the performance of the device, the
recommendations for effective use and, even more
essential, the safety precautions. On Java, all hospitals
have sufficient electrical power supplies, so the third
explanation of Bhutani and colleagues [27] does not apply.
Finally, we often found that the distances between the
model and the PT device, as installed by the nurses
according to their routine clinical practices, were too great
and often not in accordance with the manufacturers’
recommendations. Significant improvements in irradiance
could be gained if all parties involved in selling, buying,
and using PT devices were better informed about the
principles of effective PT.
Fig. 4 Bland-Altman plot showing the difference of irradiance levels of phototherapy with curtains compared to without curtains, for
phototherapy devices that have irradiance levels above 30 μw/cm2/nm. Each phototherapy device presents one dot. The mean (SD) difference
was 2.58 (4.37) μW/cm2/nm higher when using curtains (P = 0.572)
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In a few instances, we also found very high irradiance
levels - up to 127 μ W/cm2/nm. This was the case in
specific devices that delivered PT to the infant in 360
degrees and in some overhead PT devices using blue
light LEDs. Levels above 50 μ W/cm2/nm are more
effective in decreasing TSB levels faster [25, 26]. Never-
theless, several studies reported that intensive photo-
therapy may cause deoxyribonucleic acid (DNA) damage
and increased apoptosis [31–33]. One epidemiologic
study reported that infants with a history of photo-
therapy the risk of cancer is up to two times higher than
in non-exposed infants, albeit a very low absolute risk
[34]. Other studies reported a tendency towards increased
mortality, especially in extremely low birth weight in-
fants, which was not related to PT intensity, but to the
duration of PT [12, 13]. To prevent potential adverse
effects it is logical to limit the duration of PT. In
addition, an effective but short period of PT will interfere
less with parent- child interaction.
We found no overall significant effect on irradiance
levels in the case of curtains drawn around the incubator
or crib. In most hospitals on Java, curtains are used
around cribs with a PT device to protect other infants
against the light and to increase the irradiance level of
PT devices by reflection at the same time. Eggert and
colleagues suggested lining the incubator with reflective
cloth to increase the radiant power of PT devices [35].
This study was supported by studies in Germany, India,
and Malaysia that reported that a white curtain around
the PT device may reduce TSB faster, without reducing
the total time of administering PT [36–38]. The National
Institute for Health and Care Excellence (NICE) guide-
line does not recommend using curtains because it pre-
vents observing the baby [5]. As most of the curtains
used in our study were light-coloured (but not white and
possible not reflective), we believe that this may be the
explanation for the unpredictable effect we found. In
fact, this observation underlines the need to measure
irradiance. A reason for the rather wide variation between
the measurements with and without curtains might be
that we studied curtains made of different materials and
with different colors. Another study is needed to evaluate
effects of different reflective materials and of different
colors on irradiance.
Indonesia has not yet a national guideline on the man-
agement of hyperbilirubinemia and no specific recom-
mendation for phototherapy. Pediatricians in Indonesia
are advised to use the AAP guidelines for the treatment
of hyperbilirubinemia. Previously, we found that only
54% of pediatricians in Indonesia follow these guidelines
[39]. We think that a national guideline should contain
recommendations and information about phototherapy
that supports a better awareness of the requirements for
effective phototherapy.
Our study has some limitations. First, we included
only 17 hospitals on Java. This limits the generalizability
of our findings, because these 17 hospitals may not be
representative of the whole of Indonesia. We suspect
that other hospitals in other parts of the country are per-
haps less well-equipped. Our results could therefore be
an overestimation of the effectiveness of PT devices for
the whole country. Second, we used a single radiometer.
The values we found might have been different had we
used device-specific radiometers [40]. The advantage of
the radiometer we used is that it covered a wide range of
wavelengths. Third, the model we used is not a real
infant. Nevertheless, we believe that the model appro-
ximated irradiance levels quite well because we measured
at five points. Fourth, some of the PT devices in the hos-
pitals had been in use for quite some time. We were
not able to retrieve the manufacturer’s information
and specifications for nine of the 20 devices.
Our findings may have implications for clinical practice.
We recommend measuring the irradiance levels of all PT
devices in all hospitals in order to provide effective stand-
ard and intensive PT. Manufacturers should provide
essential information about the performance and safety of
their devices, in addition they should provide radiometers
to measure irradiance levels, and the hospitals should buy
them and use them. Significant improvements in
irradiance would be gained if all who sell, buy, and use PT
devices were better informed about the principles of
effective PT.
Conclusion
Half of the hospitals that we studied on Java, Indonesia,
use PT devices that provide PT levels that are too low,
while some provide very high levels of PT. Given the
risks of either insufficient PT or adverse effects, we
recommend that manufacturers provide radiometers and
that heath care providers measure irradiance to optimize
the performance of their PT devices so as to reduce the
burden of severe hyperbilirubinemia in Indonesia.
Additional file
Additional file 1: Intensity data of all phototherapy devices from
participating hospitals. (XLSX 86 kb)
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